Work

A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.5504

Authors: E. E. Vokes, E. E. W. Cohen, A. M. Mauer, T. G. Karrison, S. J. Wong, L. J. Skoog-Sluman, M. F. Kozloff, J. Dancey, A. Dekker

Institutions: University of Chicago, National Cancer Institute

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2247923872

Cites:

Cited by: 91

Related to: 10